Concepedia

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

Laura Boekel, Yaëlle R Besten, Femke Hooijberg, Rosa Wartena, Maurice Steenhuis, Erik Vogelzang, Maureen Leeuw, Sadaf Atiqi, Sander W. Tas, Willem F. Lems,

The Lancet Rheumatology · 2022 · 19 citations · 9 references

DOIFull text

Open access

Concepts

References

9

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

The Lancet · 2022 · 1.3K citations · Full text

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.

Tommy Nyberg, Neil M. Ferguson, Sophie Nash et al. · 2022 · 1.2K citations · Full text

Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

Laura Boekel, Maurice Steenhuis, Femke Hooijberg et al. · The Lancet Rheumatology · 2021 · 170 citations · Full text

Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study

The Lancet Rheumatology · 2022 · 128 citations · Full text

, , +11

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population

Femke Hooijberg, Laura Boekel, Erik H Vogelzang et al. · The Lancet Rheumatology · 2020 · 54 citations · Full text